- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07915141
Effects of Upper Extremity Physiotherapy and Home Exercises on Functional Outcomes in Individuals With Stroke
The Effect of a Physiotherapy Program Developed for the Upper Extremity in Hemiplegic İndividuals on Daily Living aAtivities and Quality of Life.
This study aims to investigate the effects of an upper extremity physiotherapy program combined with home exercises on activities of daily living, quality of life, joint range of motion, and pain in individuals with hemiplegia following stroke.
The study compares two groups: participants receiving supervised physiotherapy in addition to a home exercise program and participants performing a home exercise program only. The intervention includes stretching, range-of-motion exercises, arm ergometer training, progressive strengthening, coordination exercises, and fine motor activities.
The intervention period lasts 10 weeks. Outcomes are assessed using the Barthel Index, Short Form-36 (SF-36), Visual Analog Scale (VAS), goniometric measurements, and sensory assessments.
The study aims to evaluate whether adding supervised physiotherapy to home exercises provides additional benefits for upper extremity rehabilitation following stroke.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Gülşen Yıldız, Bachelor of Science - Lisans
- Telefonnummer: +90 551 220 29 09
- E-mail: gulsen.997178@gmail.com
Studiesteder
-
-
-
Istanbul, Tyrkiet (Türkiye)
- Avrasya Hospital Gaziosmanpaşa and zeytinburnu
-
Kontakt:
- ali emre takkin, MsC
- Telefonnummer: +90 507 154 48 87
- E-mail: aliemre.takkin@gmail.com
-
Ledende efterforsker:
- Gülşen Yıldız, BSc
-
Istanbul, Tyrkiet (Türkiye)
- Avrasya Hospital- Gaziosmanpaşa and Zeytinburnu
-
Kontakt:
- Ali Emre Takkin, MsC
- Telefonnummer: +90 507 154 48 87
- E-mail: aliemre.takkin@gmail.com
-
Ledende efterforsker:
- Gülşen Yıldız, Bsc
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Diagnosis of stroke.
- Age greater than 30 and less than 65 years.
- Time since stroke between 1 and 5 years.
- Voluntary participation in the study and treatment.
- Upper extremity Brunnstrom recovery stage 2 or 3.
- Ability to understand and perform the prescribed exercise program.
Exclusion Criteria:
- Unwillingness to continue participation in the study or treatment.
- Irregular attendance at scheduled treatment sessions.
- Upper extremity contracture severe enough to prevent exercise performance or range of motion assessment.
- Spasticity severe enough to prevent safe and effective upper extremity exercise performance.
- Failure to perform the prescribed home exercises regularly.
- Development of an additional disease or medical condition affecting upper extremity function during the study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Physiotherapy and Home Exercise Group
Participants in this group receive supervised upper extremity physiotherapy twice a week for 45 minutes over 10 weeks, in addition to a home exercise program. The physiotherapy program includes stretching, passive and active-assisted range-of-motion exercises, arm ergometer training, progressive resistance exercises using Theraband and dumbbells, coordination exercises, and fine motor activities. The home exercise program is performed five days per week, twice daily for 30 minutes per session. |
Participants in the intervention group receive a 10-week rehabilitation program consisting of supervised upper extremity physiotherapy twice weekly for 45 minutes per session and a structured home exercise program on three non-treatment days per week. The home exercise program is identical in content to that of the control group and includes upper extremity range-of-motion exercises, stretching, wall exercises, light resistance exercises using towels, Theraband and water bottles, hand-eye coordination training, and fine motor activities. Home exercises are performed twice daily for 30 minutes per session, with 10 repetitions of each exercise. Supervised physiotherapy includes stretching, passive, active-assisted and active range-of-motion exercises, wand exercises, arm ergometer training, progressive strengthening using Theraband and 0.5 kg dumbbells, coordination exercises, and fine motor activities. Participants in the control group perform a structured home exercise program five days per week for 10 weeks. The program includes upper extremity range-of-motion exercises, stretching, wall exercises, light resistance exercises using towels, Theraband and water bottles, hand-eye coordination exercises, and fine motor activities. The exercises are performed twice daily for 30 minutes per session, with 10 repetitions of each exercise. The content of the home exercise program is the same as that prescribed to the intervention group. No supervised physiotherapy sessions are provided to the control group. |
|
Aktiv komparator: Home Exercise Group
physiotherapy sessions. The program includes upper extremity range-of-motion exercises, stretching, wall exercises, light resistance exercises using towels, Theraband and water bottles, hand-eye coordination exercises, and fine motor activities. Exercises are performed five days per week, twice daily for 30 minutes per session, with 10 repetitions of each exercise. |
Participants in the control group perform a structured home exercise program five days per week for 10 weeks. The program includes upper extremity range-of-motion exercises, stretching, wall exercises, light resistance exercises using towels, Theraband and water bottles, hand-eye coordination exercises, and fine motor activities. The exercises are performed twice daily for 30 minutes per session, with 10 repetitions of each exercise. The content of the home exercise program is the same as that prescribed to the intervention group. No supervised physiotherapy sessions are provided to the control group. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Barthel Index Score
Tidsramme: Baseline (Week 1) and post-intervention (Week 10)
|
The Barthel Index is used to assess independence in activities of daily living. Total scores range from 0 to 100, with higher scores indicating greater functional independence. Changes in Barthel Index scores from baseline to the end of the 10-week intervention are compared between the intervention and control groups. |
Baseline (Week 1) and post-intervention (Week 10)
|
|
Change in SF-36 Quality of Life Scores
Tidsramme: Baseline (Week 1) and post-intervention (Week 10)
|
The SF-36 is used to assess health-related quality of life across eight domains. Scores for each domain range from 0 to 100, with higher scores indicating better health-related quality of life. Changes in scores from baseline to the end of the 10-week intervention are compared between the two groups. |
Baseline (Week 1) and post-intervention (Week 10)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Upper Extremity Range of Motion (ROM)
Tidsramme: Baseline (Week 1) and post-intervention (Week 10)
|
Upper extremity range of motion is assessed using a goniometer. Measurements include shoulder flexion, extension and abduction; elbow flexion and extension; and wrist flexion and extension. Range of motion is recorded in degrees (°), with higher values indicating greater joint mobility. Changes from baseline to Week 10 are compared between the two groups. |
Baseline (Week 1) and post-intervention (Week 10)
|
|
Change in Pain Intensity Measured by Visual Analog Scale (VAS)
Tidsramme: Baseline (Week 1) and post-intervention (Week 10)
|
Pain intensity is assessed using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity. Changes in VAS scores from baseline to the end of the 10-week intervention are compared between the intervention and control groups. |
Baseline (Week 1) and post-intervention (Week 10)
|
|
Change in Upper Extremity Sensory Function
Tidsramme: Baseline (Week 1) and post-intervention (Week 10)
|
Upper extremity sensory function is assessed using superficial, deep, and cortical sensory tests, including temperature discrimination, sharp-dull discrimination, joint position sense (proprioception), and stereognosis. Changes in sensory function from baseline to Week 10 are evaluated in both groups. |
Baseline (Week 1) and post-intervention (Week 10)
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Studiestol: Hande B Besna Göçen, PhD, Istanbul Gelisim University
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- STROKE-UE-2025-01
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Individual participant data will not be shared.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .